Dianutrilife Medica S.R.L.
- Address
- Strada Glinca Alexandru Nr. 37, 100561 Ploieşti, Romania
Dianutrilife Medica S.R.L. - Diabetes Research Center
Dianutrilife Medica S.R.L. is a specialized clinical research center dedicated to advancing diabetes care through innovative therapeutic approaches. The center focuses on evaluating novel insulin formulations and treatment regimens to optimize glycaemic control in patients with diabetes mellitus.
- Type 1 Diabetes insulin therapy optimization
- Long-acting insulin formulation studies
- Comparative efficacy trials of basal-bolus insulin regimens
The center's research portfolio includes comprehensive studies examining once-weekly insulin icodec formulations, representing cutting-edge developments in insulin delivery systems. Their work emphasizes demonstrating non-inferiority and safety profiles of novel insulin therapies compared to established treatments like insulin glargine U100, with particular attention to HbA1c outcomes and long-term metabolic control in Type 1 Diabetes patients requiring combination therapy with rapid-acting insulins.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eli Lilly & Co.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dianutrilife Medica S.R.L.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease | Eli Lilly & Co. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Insulin Glargine | 1 | Unknown | 2025-08-21 | 2025-08-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.